Eksempler på bruk av Patients in this study på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The majority of patients in this study had a baseline HbA1c of> 8%(see table 3).
Majoriteten av pasientene i denne studien hadde en baseline HbA1c på> 8 %(se tabell 3).From the 4th to the 8th year, patients were permitted the concomitant use of bisphosphonates,calcitonin and fluorides and all patients in this study received calcium and vitamin D supplementation.
Fra fjerde til åttende år kunne Patients in this study(n=1,927) received open-label CHAMPIX 1 mg twice daily for 12 weeks.
Pasienter i denne undersøkelsen(n=1927) var informert om at de fikk CHAMPIX 1 mg to ganger daglig SVR12 was achieved by 74% of patients in this study(genotype 1a: 70%, genotype 1b: 79%).
SVR12 ble oppnådd hos 74 % av pasientene i denne studien(genotype 1a: 70 %, genotype 1b: 79 %).Patients in this study had a diagnosis of PsA for at least 6 months and had at least mild psoriatic disease.
Pasientene i denne studien hadde vært diagnostisert med PsA We now plan to perform a five year follow up study(fall 2004) of the patients in this study with a confirmed full thickness cartilage injury of more than 2cm2 and a matched control group.
Vi planlegger nå en femårs oppfølging(høsten 2004) av pasientene i denne studien med påvist fulltykkelses bruskskade over 2 cm2 og en matched kontrollgruppe hentet fra det samme grunnlagsmateriale på 999 Patients in this study had no exposure to inhaled tobramycin for at least 4 months prior to study start.
Pasientene i denne studien hadde From the total of 435 patients in this study, 233 patients were treatment naïve and 202 were second line patients who received one prior IL-2 or INF-based therapy.
Av de 435 randomiserte pasientene i denne studien var 233 The patients in this study(n=452) had locally recurrent, inoperable and/or metastatic soft tissue sarcoma of one of two subtypes- leiomyosarcoma or liposarcoma.
Pasientene i denne studien(n=452) hadde lokalt residiv, inoperabel og/eller metastaserende bløtvevssarkom av én av to subtyper- leiomyosarkom eller liposarkom.A subset of patients in this study experienced acute HAE attacks while receiving androgens, antifibrinolytic agents or Cl inhibitors.
Et delsett av pasientene i denne studien opplevde akutte HAE-anfall, mens de fikk androgener, antifibrinolytiske stoffer eller C1-hemmere.Patients in this study received a dose of 50 mg LIFMIOR or placebo once weekly for 12 weeks and then all patients received open-label 50 mg LIFMIOR once weekly for an additional 12 weeks.
Pasienter i denne studien mottok en dose på 50 mg LIFMIOR eller placebo én gang per uke Patients in this study received a dose of 25 mg or 50 mg Enbrel, or placebo twice a week for 12 weeks and then all patients received open-label 25 mg Enbrel twice weekly for an additional 24 weeks.
Pasienter i denne studien mottok en dose på 25 mg eller 50 mg Enbrel eller placebo to ganger per uke There was no indication of significant improvements of the neurological manifestations of type 3 Gaucher disease except for one patient in this study.
Det var ingen indikasjon på signifikante forbedringer av de nevrologiske manifestasjonene av Gauchers sykdom type 3 unntatt for én pasient i denne studien.The number of neutropenic patients enrolled in this study was also limited 8.0.
Antallet pasienter All patients included in this study had an ECOG performance status 0 or 1.
Alle pasientene som var inkludert i denne studien hadde en ECOG-performance status på 0 eller 1.All patients included in this study had an ECOG performance status 0 or 1.
Alle pasientene i denne studien hadde en ECOG performance status på 0 eller 1.Patients involved in this study had an MMSE(Mini-Mental State Examination) score of 10- 24.
Pasientene som deltok i denne studien hadde en MMSE-score(”Mini-Mental State Examination”) på 10-24.In this study 34 patients received anagrelide for up to 5 years.
I denne studien fikk 34 pasienter anagrelid In this study 37 patients with CD(35 MCD patients) were treated with siltuximab.
I denne studien ble 37 pasienter med CD(35 MCD-pasienter) behandlet med siltuksimab.In this study 277 patients were randomised in a 2:2:1 ratio to the following arms.
I denne studien ble 277 pasienter randomisert i et 2:2:1-forhold til følgende grupper.Patients enrolled in this study had active disease despite current or previous NSAID or DMARD therapy and had not previously been treated with anti-TNF therapy.
Pasienter inkludert i denne studien hadde aktiv sykdom tross nåværende eller tidligere NSAID- eller DMARD-behandling og var ikke tidligere behandlet med anti-TNF.There were 45 different BCR-ABL mutations in 38% of patients enrolled in this study.
Det var 45 forskjellige BCR-ABL-mutasjoner hos 38 % av pasientene som ble innrullert i denne studien.All patients included in this study had to run through a training period of at least 29 days and home self-administration could start on day 36 at the earliest.
Alle pasienter innmeldt i denne studien, måtte gjennomgå en opplæringsperiode på minst 29 dager, og selvadministrasjon As there were only moderately experienced patients included in this study with an imbalance in baseline viral load between the arms, these results should be interpreted with caution.
Ettersom kun pasienter som tidligere var blitt moderat behandlet med antiretrovirale midler var inkludert i denne studien med en ubalanse Patients enrolled in this study had active disease(defined as a BASDAI≥ 4 and a Visual Analogue Scale(VAS) for total back pain of≥ 4, each on a scale of cm) despite current or previous NSAID therapy and had not previously been treated with any biological agents including anti-TNF therapy.
Pasienter inkludert i denne studien hadde aktiv sykdom(definert som BASDAI≥ 4 og en VAS for total ryggsmerte≥ 4, begge på en skala fra 0 til 10 cm) på tross av pågående eller tidligere behandling med NSAID og som ikke tidligere var behandlet med biologiske legemidler inkludert behandling med TNF-hemmere.
